Publication Date: 2023-09-18
Practice Area: Contracts
Industry: Pharmaceuticals
Court: Court of Chancery
Judge: Vice Chancellor Glasscock
Attorneys: For plaintiff: A. Thompson Bayliss, Eric A. Veres, Joseph A. Sparco, Abrams & Bayliss LLP, Wilmington, DE; Paul J. Loh, Jason H. Wilson, Eileen M. Ahern, Amelia L.B. Sargent, Peter Shimamoto, Ashley L. Kirk, Kenneth M. Trujillo-Jamison, Breeanna N. Brewer, Caitlin F. Lynch, Willenken LLP, Los Angeles, CA for plaintiff.
for defendant: Kevin R. Shannon, Christopher N. Kelly, Daniel M. Rusk, IV, Potter Anderson & Corroon LLP, Wilmington, DE; Fred A. Kelly, Jr., Joshua S. Barlow, Tiffany Jang, Arnold & Porter Kaye Scholer LLP, Washington, D.C.; Mark Basanta, Aakruti G. Vakharia, Haug Partners LLP, New York, NY; Christopher Gosselin, Haug Partners LLP, Washington, D.C. for defendant.
Case Number: 2020-0953-SG
Plaintiff's damages methodology was found mostly reliable, as the court rejected defendant's assertion that plaintiff could have mitigated its damages since the evidence showed that defendant would not have cooperated with those mitigation efforts or the success of those efforts was speculative at best.